Cargando…

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS

Detalles Bibliográficos
Autores principales:	Pisani, L.F., Mola, S., Crespi, G., Caprioli, F., Annunziata, M., Porta, C., Pastorelli, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:	Oral Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065951/ http://dx.doi.org/10.1016/S1590-8658(22)00279-1

Ejemplares similares

OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION
por: Pisani, L.F., et al.
Publicado: (2022)

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
por: Todeschini, A., et al.
Publicado: (2022)

OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM
por: Neri, B., et al.
Publicado: (2023)

OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN
por: Milluzzo, S.M., et al.
Publicado: (2021)

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2023)

OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
por: Marasco, G., et al.
Publicado: (2023)

O022. Migraineurs: seriously ill or basically healthy?
por: Panconesi, Alessandro, et al.
Publicado: (2015)

OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST
por: Costantino, A., et al.
Publicado: (2021)

OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
por: Ferretti, F., et al.
Publicado: (2021)

O022: Development of an electronic dashboard to assist surveillance
por: Wallace, S, et al.
Publicado: (2013)

PW02-022 - Recurrent fever syndromes: multiple gene mutations
por: Bohm, M, et al.
Publicado: (2013)

Laser heating system at the Extreme Conditions Beamline, P02.2, PETRA III
por: Konôpková, Zuzana, et al.
Publicado: (2021)

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
por: López Jiménez, C., et al.
Publicado: (2021)

P02-022 - Atypical cryopirin associated periodic syndrome
por: Rivas, S Bujan, et al.
Publicado: (2013)

OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
por: Termite, F., et al.
Publicado: (2023)

The Extreme Conditions Beamline P02.2 and the Extreme Conditions Science Infrastructure at PETRA III
por: Liermann, H.-P., et al.
Publicado: (2015)

OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
por: Guarino, M., et al.
Publicado: (2022)

OA02.02. Effect of MBSR and psychological state on inflammatory markers in HIV positive adults
por: Weston, E, et al.
Publicado: (2012)

O022 Response of Sleep and the Circadian System to a Long Summer Photoperiod at High Latitude
por: Guzzetti, J, et al.
Publicado: (2022)

O022 Characteristics of patients with obstructive sleep apnoea with a focus on the First Nations population
por: Bolger, M, et al.
Publicado: (2023)

O022 Long-term cardiovascular risk in obstructive sleep apnoea: a sleep clinic cohort study
por: Shenoy, B, et al.
Publicado: (2021)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

P022 Luliconazole—a novel potent imidazole activity against Aspergillus niger and Aspergillus flavus causing otomycosis
por: Sukumar, Bavadharani, et al.
Publicado: (2022)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

OC.06.9 ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE
por: Nardone, O.M., et al.
Publicado: (2021)

IT inventory and resource management with OCS inventory NG 1.02
por: Antal, Barzan
Publicado: (2010)

OC.07.2 FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY
por: Noviello, D., et al.
Publicado: (2021)

OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE
por: Germana’, B., et al.
Publicado: (2022)

OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS
por: Pelizzaro, F., et al.
Publicado: (2021)

OC-03 Heparin treatment in COVID-19 patients is associated with reduced in-hospital mortality: findings from an observational multicenter study in Italy and a meta-analysis of 11 studies
por: Costanzo, S., et al.
Publicado: (2021)

OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP
por: Nicklas, J, et al.
Publicado: (2012)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

OA03.02. Acupuncture for back pain: predicting attendance at appointments
por: Bishop, F, et al.
Publicado: (2012)

OC.01.3 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING HOSPITALIZATION DURING THE FIRST PHASE OF THE COVID-19 PANDEMIC IN VENETO REGION
por: Germana”, B., et al.
Publicado: (2021)

OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital
por: Illarramendi, J., et al.
Publicado: (2021)

Mevalonate kinase deficiency: an early onset inflammatory bowel disease?
por: Martins, A, et al.
Publicado: (2015)

Maternal mortality and its relationship to Emergency Obstetric Care (EmOC) in a tertiary care hospital in South India
por: Dasari, Papa
Publicado: (2014)

OA02.15. Anti-inflammatory and anti-proliferative activity of terpenoid fraction isolated from plectranthus hadiensis.
por: Menon, Darsan, et al.
Publicado: (2013)

A11 ISOLATION OF NON-POLAR METABOLITES IN EXCRETORY/SECRETORY PRODUCTS FROM PARASITIC HELMINTHS AND THEIR POTENTIAL AS IMMUNOTHERAPY IN INFLAMMATORY BOWEL DISEASE
por: Siciliani, E A, et al.
Publicado: (2022)

OA02.04. Integrative Health Coaching: the accumulating research at Duke IM
por: Kosey, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fi6sdevfdsrv3h448ohtpe94ku